Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6409 posts found.

Inventiva and Echosens collaborate to bring awareness to NASH and encourage screening for at-risk patients

June 8, 2023 Medical Education Echosens, Hepatology, Inventiva, liver disease, nash, non-alcoholic steatohepatitis

French clinical stage biopharmaceutical company Inventiva has announced a collaboration with US-based high-technology company Echosens to bring attention to, and …
News
1200px-vaccine_image_1

GSKโ€™s RSV vaccine approved in EU for older adults

June 7, 2023 Medical Communications EU, GSK, Infections and infestations, RSV, Vaccine

GSK has announced that the European Commission (EC) has authorised Arexvy, the companyโ€™s respiratory syncytial virus (RSV) vaccine for active …
News

Bellerophon shares top-line data from phase 3 trial of INOpulse for fILD

June 6, 2023 Medical Communications Bellerophon Therapeutics, Cardiology, clinical trials, fibrotic interstitial lung disease

Bellerophon Therapeutics has announced top-line results from its phase 3 REBUILD trial evaluating the safety and efficacy of INOpulse for …
News

Quanticate announces strategic partnership with KPS Life

June 5, 2023 Medical Communications KPS Life, Pharmacy, Quanticate, fsp

Global biometric clinical research group Quanticate has announced a strategic partnership with US-based provider of functional service provision (FSP) solutions …
News

NICE approves first treatment for obstructive HCM for NHS use

June 2, 2023 Medical Communications Bristol-Myers Squibb, Cardiology, NHS, NICE, obstructive HCM

The National Institute for Health and Care Excellence (NICE) has announced that it has approved mavacamten (Camzyos) for the treatment …
News

NICE recommends Pfizerโ€™s rimegepant for preventing episodic migraine attacks

June 2, 2023 Medical Communications NHS, NICE, Neurology, Pfizer, migraine

The National Institute for Health and Care Excellence (NICE) has announced that it has recommended an oral treatment for the …
News
towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

European Parliament shares goal to tackle antimicrobial resistance

June 2, 2023 Medical Communications EU, European Parliament, Microbiology, antimicrobial resistance

The European Parliament has shared its recommendations for a โ€œcoordinated EU response to health threats posed by antimicrobial resistance,โ€ according …
News

FDA approves ANDA of 20mg generic Nitisinone capsules

June 1, 2023 Medical Communications Analog Pharma, Dipharma, FDA, Nitisinone, Rare Diseases

Analog Pharma and Dipharma have announced that the US Food and Drug Administration (FDA) has approved their 20mg nitisinone capsules, …
News

Lonza to acquire Synaffix to strengthen ADC development

June 1, 2023 Medical Communications ADC, Lonza, Oncology, Synaffix, drug development

Global manufacturer for the pharmaceutical, biotech and nutraceutical markets, Lonza has announced that it has acquired Synaffix, a biotech company …
News

Bristol Myers Squibbโ€™s NDA accepted by FDA

May 31, 2023 Medical Communications FDA, NDA, NSCLC, Oncology, bristol myers squibb

Global pharmaceutical company Bristol Myers Squibb (BMS) has announced that its New Drug Application (NDA) has been accepted by the …
News

Pulse Medical receives FDA BDD for its ฮผFR system

May 30, 2023 Medical Communications BDD, Cardiology, FDA, Pulse Medical

Shanghai, China-based Pulse Medical Technology has announced that its 4th generation ฮผFR system has received Breakthrough Device Designation (BDD) from …
News
robina-weermeijer-ihfopazzjhm-unsplash_5

AstraZenecaโ€™s Ultomiris approved in Japan for prevention of relapses in patients with NMOSD

May 30, 2023 Medical Communications AstraZeneca, NMOSD, Neurology, Ultomiris

AstraZeneca has announced that Ultomiris (ravulizumab) has been approved in Japan as a long-acting C5 complement inhibitor for the prevention …
News

FDA approves first oral antiviral to treat adult patients with COVID-19

May 26, 2023 Medical Communications COVID-19, FDA, Infections and infestations, paxlovid

The US Food and Drug Administration (FDA) has announced that it has approved the oral antiviral Paxlovid (nirmatrelvir tablets and …
News

ZOLL remedฤ“ System receives FDA approval for sleep apnoea treatment

May 25, 2023 Medical Communications Ear Nose & throat, FDA, ZOLL, sleep apnoea

ZOLL Medical Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for its …
News
national-cancer-institute-kmvohcb-w5g-unsplash_1

AstraZeneca shares oncology data at ASCO 2023

May 25, 2023 Medical Communications ASCO, AstraZeneca, Cancer, Oncology, oncology

AstraZeneca plans to share data from its oncology pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting on …
News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026